Evidence map›Paper›PMID 35614387›Full record

ArticleBMC infectious diseases2022

Prediction and analysis of COVID-19 daily new cases and cumulative cases: times series forecasting and machine learning models.

Yanding Wang, Zehui Yan, Ding Wang, Meitao Yang, Zhiqiang Li, Xinran Gong, Di Wu, Lingling Zhai, Wenyi Zhang, Yong Wang

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yanding Wang *School of Public Health, China Medical University, Shenyang, 110122, China.
Zehui Yan *School of Public Health, China Medical University, Shenyang, 110122, China.
Ding Wang *School of Science, Beijing University of Posts and Telecommunications, Beijing, China.
Meitao YangSchool of Public Health, China Medical University, Shenyang, 110122, China.
Zhiqiang LiSchool of Public Health, China Medical University, Shenyang, 110122, China.
Xinran GongSchool of Public Health, China Medical University, Shenyang, 110122, China.
Di WuSchool of Public Health, China Medical University, Shenyang, 110122, China.
Lingling ZhaiSchool of Public Health, China Medical University, Shenyang, 110122, China.
Wenyi ZhangChinese PLA Center for Disease Control and Prevention, Beijing, 100071, China. zwy0419@126.com.
Yong WangSchool of Public Health, China Medical University, Shenyang, 110122, China. ywang7508@sina.com.
China Medical University · CN

Funding

Special Grant for the Prevention and Control of Infectious Diseases 2018ZX10713003the National Natural Science Foundation of China 12031010
6 · The paper itself

Abstract

backgroundCOVID-19 poses a severe threat to global human health, especially the USA, Brazil, and India cases continue to increase dynamically, which has a far-reaching impact on people's health, social activities, and the local economic situation.

methodsThe study proposed the ARIMA, SARIMA and Prophet models to predict daily new cases and cumulative confirmed cases in the USA, Brazil and India over the next 30 days based on the COVID-19 new confirmed cases and cumulative confirmed cases data set(May 1, 2020, and November 30, 2021) published by the official WHO, Three models were implemented in the R 4.1.1 software with forecast and prophet package. The performance of different models was evaluated by using root mean square error (RMSE), mean absolute error (MAE) and mean absolute percentage error (MAPE).

resultsThrough the fitting and prediction of daily new case data, we reveal that the Prophet model has more advantages in the prediction of the COVID-19 of the USA, which could compose data components and capture periodic characteristics when the data changes significantly, while SARIMA is more likely to appear over-fitting in the USA. And the SARIMA model captured a seven-day period hidden in daily COVID-19 new cases from 3 countries. While in the prediction of new cumulative cases, the ARIMA model has a better ability to fit and predict the data with a positive growth trend in different countries(Brazil and India).

conclusionsThis study can shed light on understanding the outbreak trends and give an insight into the epidemiological control of these regions. Further, the prediction of the Prophet model showed sufficient accuracy in the daily COVID-19 new cases of the USA. The ARIMA model is suitable for predicting Brazil and India, which can help take precautions and policy formulation for this epidemic in other countries.

Indexed as

COVID-19ForecastingHumansIndiaMachine LearningModels, StatisticalARIMACOVID-19Epidemiological dynamics predictionProphetSARIMA

Identifiers

PMID35614387
PMCPMC9131989
OpenAlexW4281483615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.